ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,744.80
0.87%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43226
-0.56%
Bitcoin
96,701.80
-0.78%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. UCB SA (UCB) Share Price

UCB SA

UCB SA (UCB)

United Communty Banks Inc
186.60
1.80
(0.97%)
Closed December 20 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
186.60
Bid
183.70
Ask
187.00
Volume
540,704
179.20 Day's Range 186.60
75.86 52 Week Range 190.20
Market Cap
36.295B
Previous Close
184.80
Open
183.90
Last Trade
235
@
186.6
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
212,883
Shares Outstanding
194,506,000
Dividend Yield
-
PE Ratio
105.82
Earnings Per Share (EPS)
1.76
Revenue
4.87B
Net Profit
343M

About UCB SA

Sector
Pharmaceutical Preparations
Industry
Chemicals & Allied Products
Website
www.ucb.com
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
1928
UCB SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker UCB. The last closing price for UCB was 184.80 €. Over the last year, UCB shares have traded in a share price range of 75.86 € to 190.20 €.

UCB currently has 194,506,000 shares outstanding. The market capitalization of UCB is 35.94 € billion. UCB has a price to earnings ratio (PE ratio) of 105.82.

Ask ADVFN Intelligence (AI)

UCB Latest News

More News

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab pegol (DZP) met its primary endpoint, demonstrating statistically and clinically significant improvement across all organ systems as measured by BICLA, an endpoint measuring disease...

November 19 2024
GlobeNewswire Inc.

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe systemic lupus erythematosus; Clinical improvements were observed among key secondary...

September 24 2024
GlobeNewswire Inc.

UCB Convening Notice to the General Meeting of the Shareholders 2024

UCB Convening Notice to the General Meeting of the Shareholders 2024 CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the ordinary...

March 22 2024
GlobeNewswire Inc.

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...

May 24 2023
GlobeNewswire Inc.

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023 CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’Administration invite les actionnaires à l’assemblée générale...

March 24 2023
GlobeNewswire Inc.

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global...

December 13 2022
GlobeNewswire Inc.

UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022

UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022 Unofficial English translation – For convenience purposes only UCB SA/NV - Public Limited Liability CompanyAllée...

March 25 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
15.93.2650802435180.7187.55178.8177280185.1835395DE
411.66.62857142857175190.2175203740183.98430038DE
1223.8514.6543778802162.75190.2160.3212883176.71473256DE
2648.535.1194786387138.1190.2133.95217059162.59385673DE
52110143.60313315976.6190.275.86255107131.86044026DE
15690.1493.448061372696.46190.265.427009097.75458005DE
260113.68155.89687328672.92190.260.1829124494.21423855DE

UCB - Frequently Asked Questions (FAQ)

What is the current UCB share price?
The current share price of UCB is 186.60 €
How many UCB shares are in issue?
UCB has 194,506,000 shares in issue
What is the market cap of UCB?
The market capitalisation of UCB is EUR 35.94B
What is the 1 year trading range for UCB share price?
UCB has traded in the range of 75.86 € to 190.20 € during the past year
What is the PE ratio of UCB?
The price to earnings ratio of UCB is 105.82
What is the cash to sales ratio of UCB?
The cash to sales ratio of UCB is 7.46
What is the reporting currency for UCB?
UCB reports financial results in EUR
What is the latest annual turnover for UCB?
The latest annual turnover of UCB is EUR 4.87B
What is the latest annual profit for UCB?
The latest annual profit of UCB is EUR 343M
What is the registered address of UCB?
The registered address for UCB is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070
What is the UCB website address?
The website address for UCB is www.ucb.com
Which industry sector does UCB operate in?
UCB operates in the CHEMICALS & ALLIED PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TMBSZTME Pharma NV
0.02 €
(185.71%)
132.5k
MLGEQGentlemen S Equity SA
0.0175 €
(118.75%)
1.14k
ALCYBCybergun
0.0002 €
(100.00%)
17.54M
MLAAHAmatheon Agri Holding NV
0.0185 €
(54.17%)
40.1k
ALARFAdeunis
0.94 €
(28.77%)
5.27k
MLSMLSmalto
0.0125 €
(-37.50%)
2.34k
MLFTIFrance Tourisme Immobilier
0.025 €
(-35.90%)
56.77k
CNVCnova NV
0.209 €
(-19.62%)
26.38k
MLWEAWeaccess Group
0.382 €
(-16.96%)
5.95k
ALEUPEuroplasma
0.0353 €
(-15.95%)
3.16M
ATOAtos SE
0.0021 €
(0.00%)
2.71B
BCPBanco Comercial Portugues SA
0.4493 €
(-0.69%)
66.54M
ALHGLouis Hachette Group
1.3342 €
(4.87%)
52.04M
KPNKoninklijke KPN NV
3.509 €
(-1.21%)
26.9M
VIVVivendi SE
2.51 €
(2.41%)
26.39M

Discussion

View Full Feed
Red_Right_Hand Red_Right_Hand 26 seconds ago
I don't see any updates at that link since the address changes on 12/11
NWBO
Frankestin Frankestin 32 seconds ago
it is good if it is used to ensnare shorts But Who know
TNXP
2020Benzo 2020Benzo 51 seconds ago
Can fly on Mon or Tues on watch!
CRKN
I-Glow I-Glow 1 minute ago
Then post your proof that Spooz had revenue of $112 Million in Q3 when Bloxcross had zero revenue in Q2.

Post your DD to prove that Spooz is shipping anything - post a Bill of Lading for one shipment.

"this valuation below is primarily from the over $100 Million in Reve
SPZI
Jack_Bolander Jack_Bolander 1 minute ago
Steve - PLUG have/has several products and applications where they are better, cleaner or more efficient , but they may not be economical to own or use.

For instance we know that in material handling applications where there are 200+ vehicles which are required to operate indoors, 24
PLUG
exwannabe exwannabe 2 minutes ago
You think that SOW was tied to a specific # of shares or a specific $ amount that would be calc'ed off current stock price? Unless LP pulls off a tremendous short squeeze that gives investors the ability to sell for astronomical prices, I envision more lawsuits questioning the conflicts of interest
NWBO
northam43 northam43 4 minutes ago
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/20/iclth6_All_Cycles_Chart.png
MightyX MightyX 4 minutes ago
Just like all yalls other falsely communicated“promises”yall claim company made just so yall would look to have a legit reason to pump n dump as the chart shows and now yall are trying to one off it on an legit individual shareholder not involved in yalls trader-group-fraud.
TPTW
HoldHigh HoldHigh 4 minutes ago
Over 2k new medical patients added to the FL OMMU site this week. Figured we'd get a bump up after Amend 3 failed.
TCNNF
barnstormer barnstormer 5 minutes ago
https://www.courtlistener.com/docket/66579590/northwest-biotherapeutics-inc-v-canaccord-genuity-llc/?form=MG0AV3
NWBO
1-1 is 4 1-1 is 4 5 minutes ago
In the long run this is good news IMO. Give it a few weeks.. hopefully it will come back with money on the books..IMO.
TNXP
r35433 r35433 5 minutes ago
Ok, what’s the deal with this one. I’m new to crypto and everyone wants their own version. Just saw this one start to trend up today.
Any input?
BONKUSD
IB_ IB_ 5 minutes ago
I just posted about all the progress being made, Mrs. Contrarian ..............

We all know what is going on with Elite, why do you feel the need to sound like you know more than everyone here ???????

The King has pointed out many of your mistakes concerning Elite .....
ELTP
dennisdave dennisdave 5 minutes ago
and I don’t advise people what to do with their money BS. You are scolding longs for trading as if they were traitors. You have been actively encouraging people to lose fast amounts of their hard earned money on this stunk.
NWBO
TAZMANS TAZMANS 5 minutes ago
Gap @ .0007
AHRO
PureZoob PureZoob 6 minutes ago
700k shares buddy…get your numbers right…And yes, Kearney works for me as he does all shareholders…
LBRMF
Dragonman1 Dragonman1 7 minutes ago
Beer is Popular it always has been, A good beer is hard to find, if sales continue go great in Canada and the US then anything is Possible, This Co can expand sales, create new clients, new customers like restaurants/bars, night clubs, liquor stores and more, cash is key, 1812 must have good cash fl
KEGS
freegriff freegriff 7 minutes ago
Whatup peeps and freaks! Came back by Ihub to wish all the Elite Pharma holders Happy Holidays. Picked the wrong horse I think but glad to see GC is letting it ride on ice for now. Who knows, maybe one day... For now, a hearty meal culpa.

Anyway, even or maybe especially to you JP, b
AMBS
blue finch blue finch 7 minutes ago
sold all shares for a profit 

wacky trading performance today 

without news this is a flipper stock

good luck to all
QBTS
sundoctor sundoctor 7 minutes ago
totally.
TSOI
cojoboy cojoboy 8 minutes ago
They never will.they live for misery.. Can not help it..sad..indeed..👌👌👌
IGPK
iamthe walrus iamthe walrus 8 minutes ago
Once they count all revenue they are talking about getting the price will have to rise . That's something we all know has to happen. Coretec said they are preparing for a NASDAQ listing then they are . There is a lot more to understand in how they do it , they know we don't family simple. There cou
CRTG
iamthe walrus iamthe walrus 8 minutes ago
Once they count all revenue they are talking about getting the price will have to rise . That's something we all know has to happen. Coretec said they are preparing for a NASDAQ listing then they are . There is a lot more to understand in how they do it , they know we don't family simple. There cou
CRTG
WorstLuck WorstLuck 8 minutes ago
LLY
more indications

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

https://investor.lilly.com/news-releases/news-release-details/fda-approves-zepboundr-tirzep
LLY

Your Recent History

EU
UCB
UCB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads